Triple

T26316619
Position Surface form Disambiguated ID Type / Status
Subject Editas Medicine E661988 entity
Predicate hasClinicalTrials P170949 FINISHED
Object CRISPR-based therapies for inherited retinal diseases LITERAL FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: CRISPR-based therapies for inherited retinal diseases | Statement: [Editas Medicine, hasClinicalTrials, CRISPR-based therapies for inherited retinal diseases]
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: hasClinicalTrials
Context triple: [Editas Medicine, hasClinicalTrials, CRISPR-based therapies for inherited retinal diseases]
  • A. hasClinicalTrialsIn
    Indicates that clinical trials related to an entity are being or have been conducted in a specified location or region.
  • B. hasClinicalTrialIdentifier
    Indicates that a clinical trial is associated with a specific identifying code or number used to uniquely reference it.
  • C. hasKeyClinicalTrial
    Indicates that an entity is associated with a primary or pivotal clinical trial that is especially important for its evaluation or approval.
  • D. coordinatesClinicalTrialsFor
    Indicates that one entity organizes, manages, or oversees the planning and execution of clinical trials on behalf of another entity.
  • E. clinicalTrialPhase
    Indicates the specific phase or stage of development a clinical trial is in within the overall clinical research process.
  • F. None of above. chosen

Provenance (4 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69ee812e73048190aae587f1d51e5a06 completed April 26, 2026, 9:18 p.m.
NER Named-entity recognition batch_69f6984bb55c8190862eb8796868d188 completed May 3, 2026, 12:35 a.m.
PD Predicate disambiguation batch_69f69661e6ec8190948251c7516a32ad completed May 3, 2026, 12:27 a.m.
PDg Predicate description generation batch_69f6978ec27c8190a488e1f9c2566d38 completed May 3, 2026, 12:32 a.m.
Created at: April 26, 2026, 10:25 p.m.